icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Cost-Effectiveness of Boceprevir Use in Patients with Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment with Peginterferon/Ribavirin
 
 
  Reported by Jules Levin
AASLD No 5-8 2011 SF
 
J. Chhatwal,1* S.A. Ferrante,2 E.J. Dasbach,2 A. El Khoury,2 B. Bacon,3 M. Burroughs,2 R. Esteban-Mur,4 C. Brass,2 E. Elbasha2 1University of Pittsburgh, Pittsburgh, PA, 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, 3Saint Louis University School of Medicine, St. Louis, MO, USA, 4Servei de Medicine Interna-Hepatologia, Valle Hebron Hospital, Barcelona, Spain

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif